Recall of CREP2 (CREATININE PLUS VER.2) FOR COBAS C701 ANALYZER

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by ROCHE DIAGNOSTICS.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    23129
  • Event Risk Class
    I
  • Event Initiated Date
    2012-11-06
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Due to a software issue on the cobas 8000 analyzer a mismatch between the reagent probe positioning on the cobas c 701 and c 702 analyzers and the aspirated reagent volumes may occur under certain high throughput conditions. this may lead to partial air pipetting at the end of the cobas c pack large possibly affecting patient sample and control recovery.

Device

  • Model / Serial
    Model Catalog: 05168597190 (Lot serial: ALL); Model Catalog: 05446376190 (Lot serial: ALL); Model Catalog: 05172373190 (Lot serial: ALL); Model Catalog: 05171873190 (Lot serial: ALL); Model Catalog: 05166888190 (Lot serial: ALL); Model Catalog: 05850797190 (Lot serial: ALL)
  • Product Description
    CREP2 (CREATININE PLUS VER.2) FOR COBAS C701 ANAL
  • Manufacturer

Manufacturer

  • Manufacturer Address
    LAVAL
  • Manufacturer Parent Company (2017)
  • Source
    HC